Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACVR1 | Q04771 | 3/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.36 |
| ▸ | TOP2A | P11388 | 1/20 | 0.36 |
| ▸ | TOP1 | P11387 | 3/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.33 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 5/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18200748 | 0.88 | ERN1 (0.37) | ACVR1ERN1TOP2ATOP1CYP3A4 | |
| SCHEMBL18200704 | 0.88 | TOP2A (0.42) | TOP2ATOP1MEN1KMT2ACYP3A4 | |
| SCHEMBL18200694 | 0.85 | TOP1 (0.43) | TOP2ATOP1CYP3A4 | |
| SCHEMBL18200567 | 0.85 | TOP2A (0.40) | TOP2AMEN1KMT2ACYP3A4 | |
| SCHEMBL18200494 | 0.82 | MEN1 (0.39) | MCL1ACMSDMEN1KMT2ADHODH | |
| SCHEMBL18200701 | 0.82 | MEN1 (0.35) | ACVR1ERN1TOP2AMCL1ACMSD | |
| SCHEMBL18200927 | 0.81 | PIM1 (0.37) | ERN1MCL1ACMSDMEN1KMT2A | |
| SCHEMBL18201248 | 0.81 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL18200873 | 0.81 | CYP3A4 (0.40) | ACVR1ERN1TOP2ACYP3A4 | |
| SCHEMBL17997923 | 0.81 | TOP2A (0.39) | TOP2ATOP1MEN1KMT2ADHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9728731-B2 | Heterocyclic compound and organic light emitting device using same | HEESUNG MATERIAL LTD. (KR) | 2017-08-08 | — | — | US | disclosed |
| US-9728731-B2 | Heterocyclic compound and organic light emitting device using same | HEESUNG MATERIAL LTD. (KR) | 2017-08-08 | — | — | US | disclosed |
| US-20160380208-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MATERIAL LTD. (KR) | 2016-12-29 | — | — | US | disclosed |
| EP-3088392-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | Heesung Material Ltd. (KR) | 2016-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160380208-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | NOTUM, DDT, CRY1 | ACVR1 3756/4885ERN1 3509/4885TOP2A 3861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.